submit to the journals

CHEST Highlights

flipper_slider

Editor's Choice

Namita Sood (University of Texas Health Science Center, Houston, TX, US) discusses challenges and advances in pulmonary arterial hypertension (PAH). Questions 1. What is the definition of pulmonary arterial...

CHEST Highlights Videos

James R Klinger (Rhode Island Hospital, and Warren Alpert Medical School, Brown University, Providence, RI, US) chats to us on the topic of his session entitled: Current Quandaries in Pulmonary Arterial Hypertension (PAH) Management. Questions 1. What are the major challenges in the...
Brian Carlin (Sleep Medicine and Lung Health Consultants LLC, and Pittsburgh Critical Care Associates, Pittsburgh, PA, US), a valued member of our Editorial Board, discusses patient and physician perspectives on inhalation devices for the treatment of chronic obstructive pulmonary disease (COPD)...
Mark L Metersky (University of Connecticut School of Medicine, Farmington, CT, US) discusses current recommendations and guidelines with respect to the use of empiric antibiotic therapy in patients with ventilator-associated pneumonia. Questions 1. What are the major challenges of empiric...
Mary E Strek (University of Chicago, Chicago, IL, US) brings us up to speed on important aspects of autoimmune lung diseases. Questions 1. How prevalent are autoimmune lung diseases? (0:10) 2. What are the major autoimmune causes of interstitial lung diseases? (0:36) 3. What are the major...
M Patricia Rivera (University of North Carolina in Chapel Hill, NC, US) provides a valuable update on lung cancer, with a focus on important points the pulmonologist needs to know and the remarkable impact of personalised therapy. Questions Part 1 1. What are the most important points the...
Brian Carlin (Sleep Medicine and Lung Health Consultants LLC, and Pittsburgh Critical Care Associates, Pittsburgh, PA, US), a valued member of our Editorial Board, talks to us about the challenge of early detection of chronic obstructive pulmonary disease (COPD) in the primary care setting and the...
Saiprakash B Venkateshiah (Emory University School of Medicine, Atlanta, GA, US) discusses obesity hypoventilation syndrome – how it's defined, signs and symptoms, diagnosis, consequences and treatment. Questions 1. What is the definition of obesity hypoventilation syndrome? (0:10) 2. What...
Jonathan H Chung (University of Chicago, Chicago, IL, US) shares his expert insights on radiology imaging of interstitial lung diseases. Questions 1. What are the most radiologic characteristics of the different types of interstitial lung disease (ILD)? (0:10) 2. What further investigations...
Ghada Bourjeily (The Miriam Hospital and Brown University, Providence, RI, US). a valued member of our Editorial Board, explains what happens to asthma during pregnancy, its potential impact, and how it is monitored and treated. Questions 1. What happens to asthma during pregnancy? (0:10) 2...
Nicola A Hanania (Baylor College of Medicine, TX, US), a valued member of our Editorial Board, talks to us about maintenance therapies in chronic obstructive pulmonary disease (COPD) with a focus on dual and triple therapy approaches. Questions 1. Following the approval of triple therapy,...
Carolyn D’Ambrosio (Brigham and Women's Hospital, Boston, MA, US) shares interesting insights on obstructive sleep apnea (OSA) and risk of cardiovascular (CV) disease in women. Questions 1. What are the mechanisms underlying the association between obstructive sleep apnea (OSA) and...
Namita Sood (University of Texas Health Science Center, Houston, TX, US) discusses challenges and advances in pulmonary arterial hypertension (PAH). Questions 1. What is the definition of pulmonary arterial hypertension (PAH)? (0:10) 2. What are the major challenges in the diagnosis of PAH...
At CHEST 2017, Jason Suggett, Group Director, Science and Technology for Trudell Medical International, presents the Aerobika* oscillating positive expiratory pressure (OPEP) device and the importance of understanding why OPEP devices should not all be considered to be the same. In COPD, the...
Brian Carlin discusses the Aerobika* oscillating positive expiratory pressure (OPEP) device and reasons to select it over other OPEP devices for the management of patients following an acute exacerbation of COPD (AECOPD) at CHEST 2017. Part 3 of 3. 1. What are the clinical outcomes associated...
Brian Carlin describes oscillating positive expiratory pressure (OPEP) devices and clinical evidence that supports them as an option for the management of patients following an acute exacerbation of COPD (AECOPD) at CHEST 2017. Part 2 of 3. 1. What are OPEP devices and what evidence is emerging...